» Articles » PMID: 4903501

Controlled Chemoprophylaxis Trials in Tuberculosis. A General Review

Overview
Journal Bibl Tuberc
Publisher Karger
Date 1970 Jan 1
PMID 4903501
Citations 199
Authors
Affiliations
Soon will be listed here.
Citing Articles

Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review.

Chihota V, Gombe M, Gupta A, Salazar-Austin N, Ryckman T, Hoffmann C Drugs. 2024; 85(2):127-147.

PMID: 39733063 PMC: 11802714. DOI: 10.1007/s40265-024-02131-3.


Isoniazid-historical development, metabolism associated toxicity and a perspective on its pharmacological improvement.

Sankar J, Chauhan A, Singh R, Mahajan D Front Pharmacol. 2024; 15:1441147.

PMID: 39364056 PMC: 11447295. DOI: 10.3389/fphar.2024.1441147.


Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study.

van Lieshout Titan A, Klaassen F, Pelissari D, de Barros Silva Junior J, Alves K, Alves L Lancet Glob Health. 2024; 12(9):e1446-e1455.

PMID: 39151980 PMC: 11339731. DOI: 10.1016/S2214-109X(24)00221-3.


Overlooked, dismissed, and downplayed: reversion of immunoreactivity.

Dale K, Schwalb A, Coussens A, Gibney K, Abboud A, Watts K Eur Respir Rev. 2024; 33(173).

PMID: 39048129 PMC: 11267292. DOI: 10.1183/16000617.0007-2024.


Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence.

Matteelli A, Churchyard G, Cirillo D, den Boon S, Falzon D, Hamada Y PLOS Glob Public Health. 2024; 4(7):e0003306.

PMID: 38954723 PMC: 11218967. DOI: 10.1371/journal.pgph.0003306.